PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21663700-5	2011	Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects.	Tyrosine	20-23	angiotensinogen	Homo sapiens	51-57	
21663700-5	2011	Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects.	Tyrosine	20-23	angiotensinogen	Homo sapiens	245-251	
21663700-5	2011	Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects.	Tyrosine	20-23	angiotensinogen	Homo sapiens	245-251	
21663700-5	2011	Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects.	Tyrosine	132-135	angiotensinogen	Homo sapiens	51-57	
21663700-5	2011	Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects.	Tyrosine	132-135	angiotensinogen	Homo sapiens	245-251	
21663700-5	2011	Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects.	Tyrosine	132-135	angiotensinogen	Homo sapiens	245-251	
21663700-5	2011	Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects.	Tyrosine	132-135	angiotensinogen	Homo sapiens	51-57	
21663700-5	2011	Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects.	Tyrosine	132-135	angiotensinogen	Homo sapiens	245-251	
21663700-5	2011	Complex PLCbeta1 is tyr-phosphorylated basally and Ang II increased SHP-2-PLCbeta1 complexes and caused complex associated PLCbeta1 tyr-phosphorylation to decline while complex associated SHP-2"s tyr-phosphorylation increased and did so via the Ang II type 1 receptors as shown by Ang II type 1 receptor blocker losartan"s effects.	Tyrosine	132-135	angiotensinogen	Homo sapiens	245-251	
21663700-6	2011	Moreover, Ang II induced both increased complex phosphatase activity and decreased complex associated PLCbeta1 tyr-phosphorylation, the latter response required regulator of G protein signaling (RGS)-2.	Tyrosine	111-114	angiotensinogen	Homo sapiens	10-16	
21663700-8	2011	Changes in the complex"s PLCbeta1 tyr-phosphorylation and SHP-2"s tyr-phosphorylation as well as SHP-2-PLCbeta1 complex formation are the result of Ang II type 1 receptor activation with changes in complex associated PLCbeta1 tyr-phosphorylation requiring RGS-2.	Tyrosine	34-37	angiotensinogen	Homo sapiens	148-154	
21663700-8	2011	Changes in the complex"s PLCbeta1 tyr-phosphorylation and SHP-2"s tyr-phosphorylation as well as SHP-2-PLCbeta1 complex formation are the result of Ang II type 1 receptor activation with changes in complex associated PLCbeta1 tyr-phosphorylation requiring RGS-2.	Tyrosine	66-69	angiotensinogen	Homo sapiens	148-154	
21663700-8	2011	Changes in the complex"s PLCbeta1 tyr-phosphorylation and SHP-2"s tyr-phosphorylation as well as SHP-2-PLCbeta1 complex formation are the result of Ang II type 1 receptor activation with changes in complex associated PLCbeta1 tyr-phosphorylation requiring RGS-2.	Tyrosine	66-69	angiotensinogen	Homo sapiens	148-154